共 49 条
[1]
Cai WW(1998)Increased caesarean section rates and emerging patterns of health insurance in Shanghai, China Am J Pub Health 88 777-80
[2]
Marks JS(2003)Rising caesarean section rates: a cause for concern? BJOG 110 346-9
[3]
Chen CH(2001)Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon Aus NZ J Obstet Gynaecol 41 411-4
[4]
Zhuang YX(2001)Comparison of two oxytocin regimens to prevent uterine atony at caesarean delivery: a randomized controlled trial Obstet Gynecol 98 386-90
[5]
Morris L(2003)Effect of the Confidential Enquiries into Maternal Deaths on the use of syntocinon at caesarean section in the UK Anaesthesia 58 277-9
[6]
Harris JR(1994)A prospective double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective caesarean section Am J Obstet Gynecol 171 1356-60
[7]
Matthews RG(1999)Double-blind comparison of carbetocin vs oxytocin in preventing uterine atony post caesarean section Am J Obstet Gynecol 181 670-6
[8]
Crowley P(2001)A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood during caesarean section Acta Obstet Gynecol Scand 80 245-50
[9]
Chong A(2004)Oxytocin requirements at elective caesarean delivery: Dose-finding study Obstet Gynecol 104 1005-10
[10]
McKenna P(2008)Use of oxytocin to prevent haemorrhage at caesarean section – A survey of practice in the United Kingdom EJOG 137 27-30